Bausch + Lomb lifts 2026 revenue guidance after Q2 sales beat, despite a slight earnings miss. Bausch + Lomb reported Q2 non-GAAP EPS of $0.15, missing estimates by $0.01. Revenue reached $1.39 billion, up 8.6% year-over-year and $20 million above expectations. The
US automaker Ford Motor lifts full-year 2026 profit forecast despite quarterly revenue decline and higher net loss. Second quarter revenue was $48.29bn, down from $50.18bn in the same period a year earlier The company said the decline was due to lower wholesale volu
Dutch energy network operator Enexis has secured a €500m ($570m) financing facility from the European Investment Bank (EIB) to support its 2026 electricity grid investment programme. The funding will be used for the expansion, reinforcement and renewal of power infrastruct
Reynolds Consumer Products raises full-year net revenue forecast after exceeding Q2 earnings and sales expectations. Reynolds Consumer Products reported Q2 non-GAAP earnings per share of $0.42, surpassing estimates by $0.02. Revenue reached $944 million, up 0.6% year-over-
The industrial technology firm reported stronger-than-expected earnings and revenue, lifting its full-year organic sales growth forecast. IDEX posted Q2 non-GAAP earnings per share of $2.32, exceeding estimates by $0.21, as revenue rose 6.4% year-over-year to $920.6M, beat
ProPetro’s Q2 results show a $0.07 per-share loss, missing expectations, while revenue of $306M slightly exceeded forecasts. ProPetro reported a Q2 GAAP loss of $0.07 per share, missing estimates by $0.05. Revenue reached $306M, beating expectations by $1.09M despite a 6.1
VRSK reports $1.98 non-GAAP EPS and $806M revenue, exceeding analyst expectations for the quarter. Verisk reported second-quarter non-GAAP earnings per share of $1.98, surpassing estimates by $0.05. Revenue reached $806 million, up 4.3% year-over-year and $1.96 million abo
By Niket Nishant and Ankur Banerjee July 29 Global shares struggled to push higher on Wednesday as modest gains in the U.S. did little to soothe investors spooked by a punishing selloff in Asia, where unease over AI valuations has frayed nerves. With sentiment towards AI-l
The medical device maker cites weaker-than-expected demand for its Watchman heart implant, pressuring revenue growth in key quarters. Boston Scientific reduced its annual profit forecast after softer demand for its Watchman device, a stroke-prevention implant for atrial fi
Procter & Gamble on Wednesday reported mixed quarterly results, as underwhelming demand for its products resulted in weaker-than-expected sales. Shares of the company fell more than 3% in premarket trading Here's what Procter & Gamble reported compared with what Wal
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.